Simple and sensitive LC-MS/MS-based assay for the quantification of dimemorfan in human plasma for use in a pharmacokinetic study

Dimemorfan phosphate has been widely used for 40 years throughout the world for the treatment of coughs. This is the first report on the use of an LC‐MS/MS‐based assay for the determination of dimemorfan in human plasma using estazolam as an internal standard after one‐step protein precipitation wit...

Full description

Saved in:
Bibliographic Details
Published inBiomedical chromatography Vol. 29; no. 5; pp. 647 - 653
Main Authors Tan, Hongyi, Peng, Jinfu, Pei, Qi, Yang, Liu, Chen, Jun, Guo, Chengxian, Hua, Ye, Yuan, Hong, Yang, Guoping
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.05.2015
Subjects
Online AccessGet full text
ISSN0269-3879
1099-0801
1099-0801
DOI10.1002/bmc.3325

Cover

More Information
Summary:Dimemorfan phosphate has been widely used for 40 years throughout the world for the treatment of coughs. This is the first report on the use of an LC‐MS/MS‐based assay for the determination of dimemorfan in human plasma using estazolam as an internal standard after one‐step protein precipitation with acetonitrile. Chromatographic separation was achieved on a Phenomenex Luna C18 column (3 µm, 50 × 2.0 mm) using a fast gradient method, which involves water and methanol as the mobile phase (both containing 0.1% formic acid). Dimemorfan and estazolam were detected with proton adducts at m/z values of 255.8 → 155.1 and 295.0 → 267.0, respectively, in the selected reaction monitoring positive mode. The linear dynamic range of the assay was 0.04–5.00 ng/mL. The chromatographic run time for each plasma sample was <5 min. The method was proven to be accurate, precise, and repeatable. Finally, the developed method was successfully applied for the determination of dimemorfan in a pharmacokinetic study using healthy Chinese subjects. Copyright © 2014 John Wiley & Sons, Ltd.
Bibliography:National Scientific Foundation of China - No. 81373476, 81302851 and 81301924
National Science and Technology Major Projects for 'Major New Drugs Innovation and Development' - No. 2012ZX09303014-001
ark:/67375/WNG-5X9M5BLB-F
Health Department Foundation of Hunan Province - No. 132013-028
Program for Science and Technology Research of Hunan Province - No. 2012WK3044
istex:92641372588EC37853780170EF04352BB5133FA4
ArticleID:BMC3325
The first two authors contributed equally to this work.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:0269-3879
1099-0801
1099-0801
DOI:10.1002/bmc.3325